Bladder Cancer Treatment Drugs Market

Market Study on Bladder Cancer Treatment Drugs: Use of Nanotechnology to Gain Prominence Going Forward

Bladder Cancer Treatment Drugs Market Segmented By Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer Type with Low-Grade Tumors, High-Grade Tumors Application

  • October-2022
  • PMRREP4465
  • 250 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Bladder Cancer Treatment Drugs Market Outlook (2022-2032)

The global bladder cancer treatment drugs market reached a size of US$ 2 Bn in 2021 and is estimated to surge to US$ 11.5 Bn by 2032, advancing at a high-value 17.2% CAGR from 2022 to 2032.

North America is expected to capture the largest share of the global bladder cancer treatment drugs market and retain the same throughout the forecast period.

Bladder Cancer Treatment Drugs Market Size (2021)

US$ 2 Bn

Projected Market Value (2032)

US$ 11.5 Bn

Global Market Growth Rate (2022-2032)

17.2% CAGR

North America Market Share (2021)

41%

Find Out More about the Report Coverage

Companies

  • GlaxoSmithKline plc
  • Novartis International AG
  • Sanofi S.A
  • Pfizer Inc.
  • Eli Lilly and Co
  • AstraZeneca plc
  • Bristol-Myers Squibb
  • F., Celgene Corporation
  • Hoffmann-La Roche AG

Which Factors are Fueling Demand for Bladder Cancer Treatment Drugs?

“High Incidence of Bladder Cancer across Regions”

The number of bladder cancer cases is increasing around the world. This is a significant factor expected to boost the global bladder cancer treatment drugs market during the forecast period. The unsanitary workplace exposures, a surge in smoking habits, and consumption of water laced with arsenic all raise the risk of bladder cancer.

  • As per the American Cancer Society, there were 81,000 new instances of bladder cancer in 2020, with 59,620 cases in males and 21,380 cases in women.

This higher prevalence of bladder cancer boosts demand for bladder cancer treatment drugs, contributing to the growth of the global market.

Moreover, a heightened awareness of bladder disorders and available treatments are projected to support the global bladder cancer treatment drugs market growth during the forecast period.

  • For example, the World Bladder Cancer Patient Coalition has named March 2022 as Bladder Cancer Awareness Month to spread awareness of warning signs and symptoms, as early diagnosis is crucial for improving long-term survival and quality of life.

“Increasing Usage of Nanotechnology”

Giant corporations are investing in research to use nanotechnology to deliver medications into the human body. Since the nanoparticles utilized in the treatment can target the malignant cells effectively without hurting the surrounding cells, this mode of delivery allows doctors to provide a straightforward and successful means of treating bladder cancer in their patients.

As a result, the increasing usage of nanotechnology is projected to aid the growth of the global bladder cancer treatment drugs market during the forecast period.

bladder-cancer-treatment-drugs-market

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

North America to Remain Global Market Leader

North America led the global bladder cancer treatment drugs market and is expected to continue during the forecast period. The existence of a large target population, growing adoption of innovative therapies, and several product launches are projected to drive the bladder cancer treatment drugs market in North America during the forecast period.

  • According to GLOBOCAN data updated in 2020, around 85,000 new cases of bladder cancer were recorded in North America in 2020, with this figure anticipated to climb to 140,000 by 2040.
  • According to the American Cancer Society's 2022 update on "Key Statistics for Bladder Cancer," approximately 80,160 new bladder cancer cases are expected to be diagnosed in the United States in 2023.

Such alarming figures are anticipated to raise the demand for bladder cancer treatment, propelling the bladder cancer treatment drugs market in North America.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Market Overview

Bladder cancer refers to the growth of abnormal tissues in the lining of the bladder. These abnormal tissues are referred to as tumors, which even spread in the surrounding tissues or muscles. Bladder cancers are basically of two types: muscle-invasive and non-muscle invasive.

When the tumor is inside the lining of the bladder, it is termed as superficial or non-muscle-invasive bladder cancer. It is the most common type of bladder cancer and is less fatal. When the tumor spreads beyond the lining of the bladder, it is termed muscle-invasive bladder cancer; it is very rare and fatal.

These bladder cancers can be further segmented into low-grade and high-grade tumors, based on their malignant potential. The standard treatment for non-muscle-invasive bladder cancer is transurethral resection of the bladder tumor. It is further followed by perioperative chemotherapy. Since bladder cancer is frequently recurrent, patients need to undergo diagnosis after every one year.

The bladder cancer treatment drugs market is growing at a significant rate due to the increasing prevalence of bladder cancer and growing awareness about the types of bladder cancers and their treatment.

Asia is expected to experience a high growth rate in the bladder cancer treatment drugs market in the next few years due to a rise in bladder cancer cases, growing need for improved bladder cancer treatments and therapies, increasing awareness about cancer diagnosis, rise in health care expenditure, and developing health care infrastructure in the region.

Increasing bladder cancer cases, technological advancements, drug innovations with regard to the treatment of bladder cancer, government initiatives, rise in the aging population, and advanced health care services are expected to drive the market for bladder cancer treatment drugs.

In addition, rise in the awareness about bladder diseases and their available therapies in the market and increasing health care expenditure are driving the global market for bladder cancer treatment drugs. However, rise in the number of patent expirations, the asymptomatic nature of the disease, and rise in the use of generic drugs are some of the major factors restraining the growth of the global bladder cancer treatment drugs market.

Growing demographics and economies in developing countries, such as India and China, are expected to lead to the rise of the bladder cancer treatment drugs market in Asia. In addition, rise in the awareness about bladder cancer and its available treatment options in the market, innovation in drug development, and subsequent technological advancements are expected to drive the market for bladder cancer treatment drugs.

Increasing number of mergers and acquisitions, rise in the number of collaborations and partnerships, new product launches, and growing awareness about the availability of bladder cancer treatment drugs are some of the latest trends that have been observed in the market.

Explore Persistence Market Research’s expertise in promulgation of the business !

Key Market Players

Some of the major companies manufacturing bladder cancer treatment drugs include Novartis International AG, Pfizer Inc., GlaxoSmithKline plc, and Sanofi S.A. In addition, some of the other companies operating in the global bladder cancer treatment drugs market include Eli Lilly and Co, AstraZeneca plc, Bristol-Myers Squibb, F. Hoffmann-La Roche AG, and Celgene Corporation.

Bladder Cancer Treatment Drugs Industry Report Scope

Attribute

Details

Forecast Period

2022-2032

Historical Data Available for

2012-2021

Market Analysis

USD Million for Value

Key Countries Covered

  • U.S.
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Russia
  • BENELUX
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Turkey
  • GCC
  • Northern Africa
  • South Africa

Key Market Segments Covered

  • Type
  • Application
  • Distribution Channel
  • Region

Key Companies Profiled

  • GlaxoSmithKline plc
  • Novartis International AG
  • Sanofi S.A
  • Pfizer Inc.
  • Eli Lilly and Co
  • AstraZeneca plc
  • Bristol-Myers Squibb
  • F., Celgene Corporation
  • Hoffmann-La Roche AG

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Bladder Cancer Treatment Drugs Industry Research Segmentation

By Type:

  • Non-Muscle-Invasive Bladder Cancer
  • Muscle-Invasive Bladder Cancer

By Application:

  • Low-Grade Tumors
  • High-Grade Tumors

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

- FAQs -

The global bladder cancer treatment drugs market is estimated to expand at a CAGR of 17.2% through 2032.

North America is expected to account for the largest share of the global bladder cancer treatment drugs market.

The global bladder cancer treatment drugs market is likely to reach US$ 11.5 Bn by 2032.

GlaxoSmithKline plc, Novartis International AG, Sanofi S.A, Pfizer Inc., Eli Lilly and Co, AstraZeneca plc, Bristol-Myers Squibb, F., Celgene Corporation, and Hoffmann-La Roche AG are leading players operating in the global market.

Recommendations

Double Chamber Prefilled Syringes Market

Convenience is a key factor driving the growth of the double chamber prefilled syringes market. Research on sterility to aid double chamber prefilled syringes..

Insulin Delivery Device Market

The global insulin delivery devices market is on the spike, and is estimated to climb up in terms of revenues, reaching US$ 14.09 Bn by 2020.

Enteral Feeding Devices Market

The growth of the home enteral nutrition market is positively influencing the enteral feeding devices market, and this trend has been observed more in developed regions as compared to developing regions..

Next Generation Iv Infusion Pumps Market

Global Next-generation IV Infusion Pumps Market study report offers comprehensive data and information about the important market dynamics & growth parameters.

Our Clients

Our Clients